erlotinib mylan 100 mg apvalkotās tabletes
mylan pharmaceuticals limited, ireland - erlotinibs - apvalkotā tablete - 100 mg
erlotinib mylan 150 mg apvalkotās tabletes
mylan pharmaceuticals limited, ireland - erlotinibs - apvalkotā tablete - 150 mg
sunitinib mylan 12,5 mg cietās kapsulas
mylan ireland limited, ireland - sunitinibs - kapsula, cietā - 12,5 mg
sunitinib mylan 50 mg cietās kapsulas
mylan ireland limited, ireland - sunitinibs - kapsula, cietā - 50 mg
pazopanib viatris 200 mg apvalkotās tabletes
viatris limited, ireland - pazopanibs - apvalkotā tablete - 200 mg
pazopanib viatris 400 mg apvalkotās tabletes
viatris limited, ireland - pazopanibs - apvalkotā tablete - 400 mg
abiraterone mylan
mylan ireland limited - abiraterona acetāts - prostatas audzēji - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
axastrol 1 mg apvalkotās tabletes
grindeks, as, latvia - anastrozols - apvalkotā tablete - 1 mg
capecitabine norameda 500 mg apvalkotās tabletes
norameda uab, lithuania - kapecitabīns - apvalkotā tablete - 500 mg
capecitabine norameda 150 mg apvalkotās tabletes
norameda uab, lithuania - kapecitabīns - apvalkotā tablete - 150 mg